Biopharma dealmaking confidence is strengthening, a new survey has revealed, but access to capital remains the defining challenge. BIO-Europe’s Biopharma C-Suite Agenda Survey 2026 surveyed 81 senior biopharma executives, including 50 CEOs. The survey results demonstrate that 75% expect partnering and M&A appetite to increase… Read More
ICON has released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe, focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. Read More
CEOs of the research-based pharmaceutical industry have issued a stark warning to the European Commission that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US. A survey of European Federation of Pharmaceutical Industries and… Read More
Resistance to change has emerged as the biggest barrier (51%) to data innovation in the pharmaceutical industry, while lack of skills is the second most cited barrier (17%). The new findings on data-driven innovation and AI in life sciences were released by the Pistoia Alliance in conjunction… Read More
More than half of labs are planning to invest in new lab automation equipment in the next two years, reflecting the importance of keeping up with constantly evolving technologies. This is one of the key findings of the DDW Research & Consultancy 2025 Research Report… Read More
The vast majority (80%) of researchers are using automation in less than half of their laboratory processes, despite the hype around these technologies. This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery Lab Automation:… Read More
When it comes to future developments in lab automation technology, the integration of artificial intelligence (AI) is the top area of anticipation for drug discovery labs. This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery… Read More
New research has revealed that 40% of workers in the pharmaceutical and life sciences sector have experienced workplace bullying, 9% above the overall average. The Resilience nation report, commissioned by regulatory and compliance software company Ideagen, gathered insights from over 4,000 individuals in… Read More
